Literature DB >> 30525987

Linking Clinical Parameters and Genotype in Dilated Cardiomyopathy.

Jared M Churko1.   

Abstract

Entities:  

Keywords:  Editorials; cardiomyopathies; cardiomyopathy, dilated; genotype; heart failure; mutation

Mesh：

Year:  2018        PMID： 30525987      PMCID： PMC6291840          DOI： 10.1161/CIRCHEARTFAILURE.118.005459

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  15 in total

1.  Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study.

Authors:  Ingrid A W van Rijsingen; Eloisa Arbustini; Perry M Elliott; Jens Mogensen; Johanna F Hermans-van Ast; Anneke J van der Kooi; J Peter van Tintelen; Maarten P van den Berg; Andrea Pilotto; Michele Pasotti; Sharon Jenkins; Camilla Rowland; Uzma Aslam; Arthur A M Wilde; Andreas Perrot; Sabine Pankuweit; Aeilko H Zwinderman; Philippe Charron; Yigal M Pinto
Journal:  J Am Coll Cardiol       Date:  2012-01-31       Impact factor: 24.094

2.  Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.

Authors:  Matthew R G Taylor; Pamela R Fain; Gianfranco Sinagra; Misi L Robinson; Alastair D Robertson; Elisa Carniel; Andrea Di Lenarda; Teresa J Bohlmeyer; Debra A Ferguson; Gary L Brodsky; Mark M Boucek; Jean Lascor; Andrew C Moss; Wai Lun P Li; Gary L Stetler; Francesco Muntoni; Michael R Bristow; Luisa Mestroni
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

3.  Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers.

Authors:  Saurabh Kumar; Samuel H Baldinger; Estelle Gandjbakhch; Philippe Maury; Jean-Marc Sellal; Alexander F A Androulakis; Xavier Waintraub; Philippe Charron; Anne Rollin; Pascale Richard; William G Stevenson; Ciorsti J Macintyre; Carolyn Y Ho; Tina Thompson; Jitendra K Vohra; Jonathan M Kalman; Katja Zeppenfeld; Frederic Sacher; Usha B Tedrow; Neal K Lakdawala
Journal:  J Am Coll Cardiol       Date:  2016-11-29       Impact factor: 24.094

4.  Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy.

Authors:  Joeri A Jansweijer; Karin Nieuwhof; Francesco Russo; Edgar T Hoorntje; Jan D H Jongbloed; Ronald H Lekanne Deprez; Alex V Postma; Marieke Bronk; Ingrid A W van Rijsingen; Simone de Haij; Elena Biagini; Paul L van Haelst; Jan van Wijngaarden; Maarten P van den Berg; Arthur A M Wilde; Marcel M A M Mannens; Rudolf A de Boer; Karin Y van Spaendonck-Zwarts; J Peter van Tintelen; Yigal M Pinto
Journal:  Eur J Heart Fail       Date:  2016-11-03       Impact factor: 15.534

Review 5.  Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline.

Authors:  Ray E Hershberger; Michael M Givertz; Carolyn Y Ho; Daniel P Judge; Paul F Kantor; Kim L McBride; Ana Morales; Matthew R G Taylor; Matteo Vatta; Stephanie M Ware
Journal:  J Card Fail       Date:  2018-03-19       Impact factor: 5.712

6.  High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.

Authors:  J Peter van Tintelen; Robert M W Hofstra; Hilga Katerberg; Tom Rossenbacker; Ans C P Wiesfeld; Gideon J du Marchie Sarvaas; Arthur A M Wilde; Irene M van Langen; Eline A Nannenberg; Anneke J van der Kooi; Marian Kraak; Isabelle C van Gelder; Dirk Jan van Veldhuisen; Yvonne Vos; Maarten P van den Berg
Journal:  Am Heart J       Date:  2007-09-14       Impact factor: 4.749

7.  Long-term outcome and risk stratification in dilated cardiolaminopathies.

Authors:  Michele Pasotti; Catherine Klersy; Andrea Pilotto; Nicola Marziliano; Claudio Rapezzi; Alessandra Serio; Savina Mannarino; Fabiana Gambarin; Valentina Favalli; Maurizia Grasso; Manuela Agozzino; Carlo Campana; Antonello Gavazzi; Oreste Febo; Massimiliano Marini; Maurizio Landolina; Andrea Mortara; Giovanni Piccolo; Mario Viganò; Luigi Tavazzi; Eloisa Arbustini
Journal:  J Am Coll Cardiol       Date:  2008-10-07       Impact factor: 24.094

8.  Titin-truncating variants affect heart function in disease cohorts and the general population.

Authors:  Sebastian Schafer; Antonio de Marvao; Eleonora Adami; Lorna R Fiedler; Benjamin Ng; Ester Khin; Owen J L Rackham; Sebastiaan van Heesch; Chee J Pua; Miao Kui; Roddy Walsh; Upasana Tayal; Sanjay K Prasad; Timothy J W Dawes; Nicole S J Ko; David Sim; Laura L H Chan; Calvin W L Chin; Francesco Mazzarotto; Paul J Barton; Franziska Kreuchwig; Dominique P V de Kleijn; Teresa Totman; Carlo Biffi; Nicole Tee; Daniel Rueckert; Valentin Schneider; Allison Faber; Vera Regitz-Zagrosek; Jonathan G Seidman; Christine E Seidman; Wolfgang A Linke; Jean-Paul Kovalik; Declan O'Regan; James S Ware; Norbert Hubner; Stuart A Cook
Journal:  Nat Genet       Date:  2016-11-21       Impact factor: 38.330

9.  Common sequence variants affect molecular function more than rare variants?

Authors:  Yannick Mahlich; Jonas Reeb; Maximilian Hecht; Maria Schelling; Tjaart Andries Petrus De Beer; Yana Bromberg; Burkhard Rost
Journal:  Sci Rep       Date:  2017-05-09       Impact factor: 4.379

10.  Recovery of Cardiac Function in Cardiomyopathy Caused by Titin Truncation.

Authors:  Leanne E Felkin; Roddy Walsh; James S Ware; Magdi H Yacoub; Emma J Birks; Paul J R Barton; Stuart A Cook
Journal:  JAMA Cardiol       Date:  2016-05-01       Impact factor: 14.676
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.